Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
About this item
Full title
Author / Creator
Schalper, Kurt A. , Rodriguez-Ruiz, Maria E. , Diez-Valle, Ricardo , López-Janeiro, Alvaro , Porciuncula, Angelo , Idoate, Miguel A. , Inogés, Susana , de Andrea, Carlos , López-Diaz de Cerio, Ascensión , Tejada, Sonia , Berraondo, Pedro , Villarroel-Espindola, Franz , Choi, Jungmin , Gúrpide, Alfonso , Giraldez, Miriam , Goicoechea, Iosune , Gallego Perez-Larraya, Jaime , Sanmamed, Miguel F. , Perez-Gracia, Jose L. and Melero, Ignacio
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Glioblastoma is the most common primary central nervous system malignancy and has a poor prognosis. Standard first-line treatment, which includes surgery followed by adjuvant radio-chemotherapy, produces only modest benefits to survival
1
,
2
. Here, to explore the feasibility, safety and immunobiological effects of PD-1 blockade in pat...
Alternative Titles
Full title
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Authors, Artists and Contributors
Author / Creator
Rodriguez-Ruiz, Maria E.
Diez-Valle, Ricardo
López-Janeiro, Alvaro
Porciuncula, Angelo
Idoate, Miguel A.
Inogés, Susana
de Andrea, Carlos
López-Diaz de Cerio, Ascensión
Tejada, Sonia
Berraondo, Pedro
Villarroel-Espindola, Franz
Choi, Jungmin
Gúrpide, Alfonso
Giraldez, Miriam
Goicoechea, Iosune
Gallego Perez-Larraya, Jaime
Sanmamed, Miguel F.
Perez-Gracia, Jose L.
Melero, Ignacio
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2189196038
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2189196038
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/s41591-018-0339-5
